The underlying cause of LCHADD retinopathy is not fully understood. This presentation will look at the research that identifies the cell in the eye that is initially affected and characteristics associated with vision loss. Join Dr. Gillingham as she discusses early data on the natural history study and some new pre-clinical models to test novel treatments for LCHADD retinopathy.
lanning for your future with Mito… a workshop for parents & adult patients Monthly International Teleconference Outreach “It feels like each day is all...
Organizations share what they have planned for the next 12 months. The annual town meeting is our way of kicking off the new year...
The annual town hall meeting is MitoAction’s way of kicking off the new year by sharing all that we have in store for the...
